Castleman Disease and Renal Amyloidosis
Authors: I. Kazes
Journal: Annals of Internal Medicine (1995)

Letters1 March 1995Castleman Disease and Renal AmyloidosisI. Kazes, G. Deray, and C. JacobsI. KazesHopital Pitie-Salpetriere, Paris, France.Search for more papers by this author, G. DerayHopital Pitie-Salpetriere, Paris, France.Search for more papers by this author, and C. JacobsHopital Pitie-Salpetriere, Paris, France.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-122-5-199503010-00024 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Giant lymph node hyperplasia was initially described by Castleman and colleagues [1] in 1956 as a solitary mediastinal lesion. Since then, isolated cases of this rare disease have been reported in other sites [2] and have been described under two clinicopathologic variants: the hyaline vascular type and the plasma cell type. Systemic manifestations such as fever, anemia, increased erythrocyte sedimentation rate, and hypergammaglobulinemia frequently accompany the plasma cell variant and subside after the lesion is removed [3]. We describe a patient successfully treated with surgery alone for Castleman disease associated with renal amyloidosis.A 48-year-old woman who ...References1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer. 1956; 9:822-30. Google Scholar2. Keller AR, Hocholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972; 29:670-83. Google Scholar3. Ordi J, Grau JM. Secondary (AA) amyloidosis associated with Castleman's disease. Hematopathology. 1993; 100:394-7. Google Scholar4. Beck JT, Hsu SM, Wijdenes J, Bataille R. Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med. 1994; 330:602-5. Google Scholar Author, Article, and Disclosure InformationAuthors: I. Kazes; G. Deray; C. JacobsAffiliations: Hopital Pitie-Salpetriere, Paris, France. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byAA amyloidosis associated with Castleman diseaseRenal complications of Castleman’s disease: report of two cases and analysis of 75 casesRenal involvement in Castleman diseaseAn autopsy case of multicentric Castleman’s disease associated with interstitial nephritis and secondary AA amyloidosisIrreversible Kidney Damage due to Multicentric Castleman’s DiseaseMaladie de Behçet très thrombogène associée à une maladie de Castelman et à une amylose rénaleLaparoscopic Treatment of Unicentric Castleman's Disease with Abdominal LocalizationAnaesthetic Considerations in Castleman's DiseaseLOCALISED PLASMA-CELL TYPE CASTLEMAN’S DISEASE AND AA-AMYLOIDOSIS CURED BY RESECTION. A CASE REPORT AND REVIEW OF THE LITERATURERemission of nephrotic syndrome after removal of localized castleman's diseaseSystemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum. 1 March 1995Volume 122, Issue 5Page: 395-396KeywordsAmyloidosisAnemiaCreatinineErythrocyte sedimentation rateHemoglobinLesionsPlasma cellsRenal diseasesSurgerySurgical resection ePublished: 15 August 2000 Issue Published: 1 March 1995 Copyright & PermissionsCopyright © 1995 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...